GLOBAL (NORTH AMERICA, EUROPE, ASIA-PACIFIC, SOUTH AMERICA, MIDDLE EAST AND AFRICA) EOSINOPHILIC ESOPHAGITIS DRUG MARKET 2018, FORECAST TO 2023

Aug 2018 130

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.

Scope of the Report:
This report focuses on the Eosinophilic Esophagitis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of eosinophilic esophagitis drug includes budesonide, fluticasone and other types, and the proportion of budesonide in 2017 is about 52%.
North America is the largest consumption region of eosinophilic esophagitis drug, with a sales market share nearly 32% in 2017. Europe is the second largest consumption region of eosinophilic esophagitis drug, enjoying Sales market share nearly 29% in 2017.
Market competition is intense. AstraZeneca, GSK, Bayer are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Eosinophilic Esophagitis Drug is expected to grow at a CAGR of roughly 6.2% over the next five years, will reach 150 million US$ in 2023, from 100 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
- AstraZeneca
- GSK
- Bayer
- Adare Pharmaceuticals
- DBV Technologies
- Dr. Falk Pharma
- Quorum Innovations
- Shire
- Calypso
- Celgene
- Regeneron

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Budesonide
- Fluticasone
- Others

Market Segment by Applications, can be divided into
- Hospitals
- Clinics
- Drugstore

There are 15 Chapters to deeply display the global Eosinophilic Esophagitis Drug market.
Chapter 1, to describe Eosinophilic Esophagitis Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Eosinophilic Esophagitis Drug, with sales, revenue, and price of Eosinophilic Esophagitis Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Eosinophilic Esophagitis Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Eosinophilic Esophagitis Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Eosinophilic Esophagitis Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Dec 19)

Description Scope of the Report: The worldwide market for L-Carnitine Supplements is expected to grow at a CAGR of rou...

(Dec 19)

Description Scope of the Report: The worldwide market for Pseudorabies Virus Vaccine is expected to grow at a CAGR of ...

(Dec 19)

Description Scope of the Report: The worldwide market for Bromfenac Sodium (CAS 91714-93-1) is expected to grow at a C...

(Dec 19)

Description Scope of the Report: The worldwide market for Nedaplatin (CAS 95734-82-0) is expected to grow at a CAGR of...

(Dec 19)

Description Scope of the Report: The worldwide market for Epirubicin (CAS 56420-45-2) is expected to grow at a CAGR of...

(Dec 19)

Description Scope of the Report: The worldwide market for Altretamine (CAS 645-05-6) is expected to grow at a CAGR of ...

GLOBAL (NORTH AMERICA, EUROPE, ASIA-PACIFIC, SOUTH AMERICA, MIDDLE EAST AND AFRICA) EOSINOPHILIC ESOPHAGITIS DRUG MARKET 2018, FORECAST TO 2023

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy